Improved guideline adherence may not overcome evidence gaps in severe trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia infection: a case-based perspective | Synapse
March 3, 2026Open Access
Improved guideline adherence may not overcome evidence gaps in severe trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia infection: a case-based perspective
Key Points
Improved guideline adherence may not significantly change outcomes in resistant infections.
Trimethoprim-sulfamethoxazole resistance is noted in serious Stenotrophomonas maltophilia cases.
Observational analysis focused on case-based perspectives to identify evidence gaps.
The findings highlight the need for updated guidelines and further investigation into treatment options.